Indicated for schizophrenia and bipolar disorder to manage psychiatric symptoms and support behavioral regulation.
Mechanism of Action
Risperidone is a selective monoaminergic antagonist with high affinity for serotonin Type 2 (5-HT2) and dopamine Type 2 (D2) receptors. It also binds to alpha-1, alpha-2, and H1 histaminergic receptors.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
20–24 hours
Contraindications
Hypersensitivity to risperidone, History of qt prolongation
Severe Adverse Events
Neuroleptic malignant syndrome, Tardive dyskinesia, Stroke in elderly patients — requires immediate medical attention
Information related to Risperdal is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
